William van Kampen, Xoran Chief Technology Officer and principal investigator on the project.

William van Kampen, Xoran Chief Technology Officer and principal investigator on the project. 


June 24, 2022 — Xoran Technologies announced they have begun work on Phase 2 of their mobile lung grant with the goal to confirm the safety and utility of a future thoracic point-of-care CT system in support of an FDA 510k submission. 

“It’s hard to overstate how transformative this technology would be for us in the ICU,” says Robert Dickson, MD, Associate Professor—Pulmonary & Critical Care Medicine, Associate Professor—Microbiology & Immunology, and a clinical collaborator, all at the University of Michigan. “Every day, we make clinical decisions based on chest X-rays, which are limited in what they can tell us about what is going on in the chest or abdomen. Our patients are often too sick to transport down to radiology, or they have a communicable disease like COVID-19 that we don’t want to spread around the hospital. A bedside scanner would have immediate impact in how we manage our sickest patients.” 

In 2021, Xoran Technologies was notified of a grant award from the National Heart, Lung, and Blood Institute (NHLBI) through the National Institutes of Health (NIH) to support the company’s research and development efforts for lung cone beam computed tomography (CT) imaging. Earlier this year, Xoran announced they completed Phase 1 of this grant. Just last month, Xoran submitted its 510k for TRON, an open-bore fluoroscopy CT for full-body point-of-care imaging. 

“We greatly appreciate the support from NHLBI as well as a fantastic collaboration with doctors at the University of Michigan,” states William van Kampen, Xoran’s Chief Technology Officer and principal investigator on the project. “This grant enables us to obtain valuable clinical feedback and accelerate our commercialization of this exciting technology and help bring imaging to patients who are in great need.” 

This project allows Xoran to optimize a point-of-care solution specifically for lung imaging. The combined Xoran and UofM teams aim to develop a highly deployable CT scanner intended for use in ICU, especially for patients with acute respiratory failure requiring mechanical ventilation. 

For more information: www.xorantech.com 

Related Content

News | Radiation Oncology

August 15, 2022 — A new study published by University of Kentucky Markey Cancer Center researchers suggests that the ...

Time August 15, 2022
arrow
News | Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

Time August 08, 2022
arrow
News | Computed Tomography (CT)

August 4, 2022 — Xoran Technologies announces that last month it received FDA 510(k) clearance for TRON — a truly mobile ...

Time August 04, 2022
arrow
News | Contrast Media

August 3, 2022 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), electronic health ...

Time August 03, 2022
arrow
News | Lung Imaging

August 3, 2022 — Structural differences in lung airways between men and women may be the cause of differences in chronic ...

Time August 03, 2022
arrow
News | Contrast Media

August 2, 2022 – A new update has been announced as the radiology world continues to address supply disruptions of ...

Time August 02, 2022
arrow
Feature | Lung Imaging

August 1, 2022 — In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources ...

Time August 01, 2022
arrow
News | ECR

July 25, 2022 — Dunlee unveiled its new oncology bundles for the first time this year, launched at the 2022 European ...

Time July 25, 2022
arrow
News | AHRA

July 18, 2022 — 3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging ...

Time July 19, 2022
arrow
News | Contrast Media

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

Time July 18, 2022
arrow
Subscribe Now